108 related articles for article (PubMed ID: 3497637)
21. The influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjects.
Boni JP; Cevallos WH; DeCleene S; Korth-Bradley JM
Pharmacotherapy; 1997; 17(4):783-90. PubMed ID: 9250558
[TBL] [Abstract][Full Text] [Related]
22. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Bucci FA; Waterbury LD
J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
[TBL] [Abstract][Full Text] [Related]
23. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
24. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
Jones J; Francis P
Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
[TBL] [Abstract][Full Text] [Related]
25. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological properties of 2-[4-(2-thiazolyloxy)-phenyl]-propionic acid (480156-S), a new non-steroidal antiinflammatory agent.
Hirose K; Jyoyama H; Kojima Y; Eigyo M; Hatakeyama H; Asanuma F; Umehara H; Yamaguchi T
Arzneimittelforschung; 1984; 34(3):280-6. PubMed ID: 6610429
[TBL] [Abstract][Full Text] [Related]
28. Suprofen, a new peripheral analgesic.
Capetola RJ; Shriver DA; Rosenthale ME
J Pharmacol Exp Ther; 1980 Jul; 214(1):16-23. PubMed ID: 6993657
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological properties of a new anti-inflammatory agent: 2-(2-isopropyl-5-indanyl)propionic acid (UP 517-03).
Hertz F; Ranson M; Lwoff JM
Arzneimittelforschung; 1980; 30(9):1549-57. PubMed ID: 6970037
[TBL] [Abstract][Full Text] [Related]
30. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood.
Verster JC; Veldhuijzen DS; Volkerts ER
Clin J Pain; 2006 Jun; 22(5):499-504. PubMed ID: 16772806
[TBL] [Abstract][Full Text] [Related]
31. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
32. Suprofen, a potent antagonist of acetic acid-induced writhing in rats.
Niemegeers CJ; Van Bruggen JA; Janssen PA
Arzneimittelforschung; 1975 Oct; 25(10):1505-9. PubMed ID: 1243029
[TBL] [Abstract][Full Text] [Related]
33. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacokinetics and pharmacodynamics of bromfenac.
Skjodt NM; Davies NM
Clin Pharmacokinet; 1999 Jun; 36(6):399-408. PubMed ID: 10427465
[TBL] [Abstract][Full Text] [Related]
35. Comparative studies on the amino acid derivatives of indometacin.
Krupińska J; Mazur J; Piotrowicz J; Cebo B; Stephanus R
Pol J Pharmacol Pharm; 1986; 38(2):149-56. PubMed ID: 3092202
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification.
Mukai K; Matsushima H; Gotoh N; Aose M; Satoshi W; Wataru T; Matsui E; Nagata M; Senoo T
J Cataract Refract Surg; 2009 Sep; 35(9):1614-8. PubMed ID: 19683162
[TBL] [Abstract][Full Text] [Related]
37. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
[TBL] [Abstract][Full Text] [Related]
38. [Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation].
Ogawa T; Sakaue T; Terai T; Fukiage C
Nippon Ganka Gakkai Zasshi; 1995 Apr; 99(4):406-11. PubMed ID: 7741052
[TBL] [Abstract][Full Text] [Related]
39. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
40. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
